Evidence mapPaperPMID 26426115Full record

ArticlePloS one2015

Glycerol Production from Glucose and Fructose by 3T3-L1 Cells: A Mechanism of Adipocyte Defense from Excess Substrate.

María del Mar Romero, David Sabater, José Antonio Fernández-López, Xavier Remesar, Marià Alemany

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. High Fructose Intake and Adipogenesis.International journal of molecular sciences · 2019
    Review
  12. Article
  13. Sphingolipids in adipose tissue: What's tipping the scale?Advances in biological regulation · 2018
    Review
  14. Article
  15. Use ofAdipocyte · 2018
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

María del Mar RomeroDepartment of Nutrition and Food Science, Faculty of Biology, University of Barcelona, Av.Diagonal 643, 08028, Barcelona, Spain; Institute of Biomedicine, University of Barcelona, Barcelona, Spain; CIBER Obesity and Nutrition, Barcelona, Spain.
David SabaterDepartment of Nutrition and Food Science, Faculty of Biology, University of Barcelona, Av.Diagonal 643, 08028, Barcelona, Spain.
José Antonio Fernández-LópezDepartment of Nutrition and Food Science, Faculty of Biology, University of Barcelona, Av.Diagonal 643, 08028, Barcelona, Spain; Institute of Biomedicine, University of Barcelona, Barcelona, Spain; CIBER Obesity and Nutrition, Barcelona, Spain.
Xavier RemesarDepartment of Nutrition and Food Science, Faculty of Biology, University of Barcelona, Av.Diagonal 643, 08028, Barcelona, Spain; Institute of Biomedicine, University of Barcelona, Barcelona, Spain; CIBER Obesity and Nutrition, Barcelona, Spain.
Marià AlemanyDepartment of Nutrition and Food Science, Faculty of Biology, University of Barcelona, Av.Diagonal 643, 08028, Barcelona, Spain; Institute of Biomedicine, University of Barcelona, Barcelona, Spain; CIBER Obesity and Nutrition, Barcelona, Spain.
Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cultured adipocytes (3T3-L1) produce large amounts of 3C fragments; largely lactate, depending on medium glucose levels. Increased glycolysis has been observed also in vivo in different sites of rat white adipose tissue. We investigated whether fructose can substitute glucose as source of lactate, and, especially whether the glycerol released to the medium was of lipolytic or glycolytic origin. Fructose conversion to lactate and glycerol was lower than that of glucose. The fast exhaustion of medium glucose was unrelated to significant changes in lipid storage. Fructose inhibited to a higher degree than glucose the expression of lipogenic enzymes. When both hexoses were present, the effects of fructose on gene expression prevailed over those of glucose. Adipocytes expressed fructokinase, but not aldolase b. Substantive release of glycerol accompanied lactate when fructose was the substrate. The mass of cell triacylglycerol (and its lack of change) could not justify the comparatively higher amount of glycerol released. Consequently, most of this glycerol should be derived from the glycolytic pathway, since its lipolytic origin could not be (quantitatively) sustained. Proportionally (with respect to lactate plus glycerol), more glycerol was produced from fructose than from glucose, which suggests that part of fructose was catabolized by the alternate (hepatic) fructose pathway. Earlier described adipose glycerophophatase activity may help explain the glycolytic origin of most of the glycerol. However, no gene is known for this enzyme in mammals, which suggests that this function may be carried out by one of the known phosphatases in the tissue. Break up of glycerol-3P to yield glycerol, may be a limiting factor for the synthesis of triacylglycerols through control of glycerol-3P availability. A phosphatase pathway such as that described may have a potential regulatory function, and explain the production of glycerol by adipocytes in the absence of lipolytic stimulation.

Indexed as

3T3-L1 CellsAdipocytesAnimalsCells, CulturedFructoseGene Expression RegulationGlucoseGlycerolGlycolysisMiceRatsReal-Time Polymerase Chain ReactionFructoseGlucoseGlycerol

Identifiers

PMID26426115
PMCPMC4591265
OpenAlexW1941673548

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.